Vertex Pharmaceuticals VRTX Total CF product revenues, net — Total revenues

Other product segments

Similar metrics at other companies

RYTMProduct revenue, net — Total revenues

$60.11M+59.4%

BMRNNet product revenues — Total revenues

$760.08M+3.5%

EXELNet product revenues — Total revenues

$554.98M+8.1%

ZBRACF — Total Net Sales

$825M+20.6%

TVTXTotal net product sales — Total Revenue

$124.49M+64.1%

NBIXNet product sales — Total revenues

$811M+43.9%

Questions, answered.

What is Vertex Pharmaceuticals's total CF product revenues, net — total revenues?

Vertex Pharmaceuticals (VRTX) reported total CF product revenues, net — total revenues of $2.92B in Q1 2026.

What does total CF product revenues, net — total revenues mean?

This metric represents the aggregate net sales generated from the company's portfolio of cystic fibrosis therapeutic products. It serves as the primary revenue stream for the organization, reflecting the market adoption and commercial success of its core disease-modifying treatments. Monitoring this figure provides insight into the company's ability to maintain its standard-of-care position within the cystic fibrosis market.